Coronary artery disease (CAD) is the number one cause of death for men and women in the United States and is a significant cause of morbidity and mortality for individuals age 65 years and older. A significant medical advance in the prevention and treatment of CAD has been the implementation of lipid-lowering therapy to treat elevated cholesterol. Some clinicians, however, have lingering questions about when to treat hyperlidemia in elderly patients. This article will review the available data on the impact of statin therapy on cardiovascular risk reduction in the elderly.
|Original language||English (US)|
|Number of pages||6|
|Journal||Annals of Long-Term Care|
|State||Published - Jun 1 2003|
ASJC Scopus subject areas
- Geriatrics and Gerontology